EXHIBIT 10.26 PURCHASE AGREEMENT Agreement made as of the 10 day of October, 2005 (the "Agreement Date"), between Altus Pharmaceuticals Inc., a Delaware corporation with its principal office at 125 Sidney Street, Cambridge, MA 01239, USA ("ALTUS"),...Purchase Agreement • January 11th, 2006 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • New York
. . Exhibit 10.21 LEASE FOR 125 SIDNEY STREET PROPERTY 1. PARTIES Rizika Realty Trust (whose mailing address is: 36 Edgehill Road, Brookline, MA 02445), the LESSOR, which expression shall include his heirs, successors, and assigns where the context so...Lease Agreement • October 17th, 2005 • Altus Pharmaceuticals Inc.
Exhibit 10.18 November 24, 2004 Mr. Peter L. Lanciano 66 White Wood Road Milford, MA 01757 Dear Peter: The purpose of this letter agreement ("Agreement") is to set forth the terms of your separation from Altus Pharmaceuticals Inc. (the "Company"). The...Separation Agreement • November 30th, 2005 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • Massachusetts
Exhibit 1.1 ALTUS PHARMACEUTICALS INC. (a Delaware corporation) 6,000,000 Shares of Common Stock PURCHASE AGREEMENT Dated: -, 2006 ALTUS PHARMACEUTICALS INC. (a Delaware corporation) 6,000,000 Shares of Common Stock (Par Value $.01 Per Share) PURCHASE...Purchase Agreement • January 11th, 2006 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • New York
SUBLEASESublease Agreement • October 17th, 2005 • Altus Pharmaceuticals Inc. • Massachusetts
SUBLEASESublease • October 17th, 2005 • Altus Pharmaceuticals Inc.
Exhibit 4.8 THIS WARRANT, AND THE SECURITIES ISSUABLE HEREUNDER, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, (THE "ACT') OR THE APPLICABLE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS...Warrant Agreement • October 17th, 2005 • Altus Pharmaceuticals Inc. • Massachusetts
Exhibit 4.7 NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. NO SALE OR DISPOSITION MAY BE EFFECTED EXCEPT IN COMPLIANCE WITH RULE 144 UNDER SAID ACT OR...Warrant Agreement • October 17th, 2005 • Altus Pharmaceuticals Inc. • Connecticut
RECITALSManufacturing Agreement • February 6th, 2007 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • England and Wales
Exhibit 10.6 NON-QUALIFIED STOCK OPTION AGREEMENT ALTUS PHARMACEUTICALS INC. AGREEMENT made as of the AGREEMENT DATE, between Altus Pharmaceuticals Inc. (the "Company"), a Delaware corporation having a principal place of business in Cambridge,...Non-Qualified Stock Option Agreement • October 17th, 2005 • Altus Pharmaceuticals Inc. • Delaware
andStrategic Alliance Agreement • January 23rd, 2006 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • Massachusetts
Exhibit 10.13 TECHNOLOGY LICENSE AGREEMENT Agreement made as of the 1st day of February, 1999 (the "Effective Date"), between VERTEX PHARMACEUTICALS INCORPORATED, a Massachusetts corporation (together with its Affiliates, "Vertex"), and ALTUS...Technology License Agreement • January 11th, 2006 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • Massachusetts
Exhibit 10.9 MASTER LOAN AND SECURITY AGREEMENTMaster Loan and Security Agreement • October 17th, 2005 • Altus Pharmaceuticals Inc. • Virginia
EXHIBIT 10.6.1 ALTUS PHARMACEUTICALS INC. NON-QUALIFIED STOCK OPTION AGREEMENT AGREEMENT made as of the <>, between Altus Pharmaceuticals Inc. (the "Company"), a Delaware corporation having a principal place of business in Cambridge, Massachusetts,...Non-Qualified Stock Option Agreement • January 11th, 2006 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • Delaware
RECITALSIndemnification Agreement • November 30th, 2005 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • Delaware
MASTER SECURITY AGREEMENT NO. 4081067 Dated as of AUGUST 19, 2004 ("AGREEMENT")Master Security Agreement • October 17th, 2005 • Altus Pharmaceuticals Inc. • Virginia
Recitals:Stockholders' Voting Agreement • November 30th, 2005 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • Delaware
RecitalsRight of First Refusal and Co-Sale Agreement • October 17th, 2005 • Altus Pharmaceuticals Inc. • Delaware
Exhibit 10.5 INCENTIVE STOCK OPTION AGREEMENT ALTUS PHARMACEUTICALS INC. AGREEMENT made as of the AGREEMENT DATE, between Altus Pharmaceuticals Inc. (the "Company"), a Delaware corporation having a principal place of business in Cambridge,...Incentive Stock Option Agreement • October 17th, 2005 • Altus Pharmaceuticals Inc. • Delaware
Exhibit 10.3 ALTUS BIOLOGICS INC. 1993 STOCK OPTION PLAN NON-QUALIFIED STOCK OPTION AGREEMENT This Stock Option Agreement sets forth the terms and conditions of an Option granted pursuant to the provisions of the 1993 Stock Option Plan (as from time...Non-Qualified Stock Option Agreement • October 17th, 2005 • Altus Pharmaceuticals Inc.
PROMISSORY NOTEPromissory Note • October 17th, 2005 • Altus Pharmaceuticals Inc.
Exhibit 10.2 ALTUS BIOLOGICS INC. 1993 STOCK OPTION PLAN INCENTIVE STOCK OPTION AGREEMENT This Stock Option Agreement sets forth the terms and conditions of an Option granted pursuant to the provisions of the 1993 Stock Option Plan (as from time tot...Incentive Stock Option Agreement • October 17th, 2005 • Altus Pharmaceuticals Inc.
EXHIBIT 10.1 PORTIONS OF THIS EXHIBIT WERE OMITTED AND HAVE BEEN FILED SEPARATELY WITH THE SECRETARY OF THE COMMISSION PURSUANT TO THE COMPANY'S APPLICATION REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 24B-2 OF THE EXCHANGE ACT. COLLABORATION AND...Collaboration and License Agreement • February 1st, 2007 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • New York
RecitalsInvestor Rights Agreement • October 17th, 2005 • Altus Pharmaceuticals Inc. • Delaware
PROMISSORY NOTE To Master Security Agreement No. 4081067 August 31, 2004 (Date)Promissory Note • October 17th, 2005 • Altus Pharmaceuticals Inc. • Virginia
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • May 5th, 2009 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Agreement (the “Agreement”) is entered into as of the 30th day of April, 2009 by and between Altus Pharmaceuticals Inc., a Delaware corporation (the “Company”), and Thomas J. Phair, Jr. (the “Executive”).
RECITALSAssignment of Lease • October 17th, 2005 • Altus Pharmaceuticals Inc. • Washington
Exhibit 10.8 MASTER LEASE AGREEMENT dated as of May 21, 2002, ("Agreement") THIS AGREEMENT is between GENERAL ELECTRIC CAPITAL CORPORATION (together with its successors and assigns, if any, "LESSOR") and ALTUS BIOLOGICS INC. ("LESSEE"). Lessor has an...Master Lease Agreement • October 17th, 2005 • Altus Pharmaceuticals Inc.
andStrategic Alliance Agreement • November 2nd, 2005 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • Massachusetts
WITNESSETH:Cooperative Development Agreement • December 27th, 2005 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances)
BETWEENDevelopment, Commercialization and Marketing Agreement • January 11th, 2006 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • Massachusetts
WITNESSETH:Cooperative Development Agreement • January 23rd, 2006 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances)
ARTICLE I VOTING OF SHARESVoting Standstill Agreement • October 17th, 2005 • Altus Pharmaceuticals Inc. • Delaware
Altus Pharmaceuticals Inc. February 4, 2008Separation Agreement • March 11th, 2008 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • Massachusetts
The purpose of this letter agreement (the “Agreement”) is to set forth the terms of your resignation from Altus Pharmaceuticals Inc. (the “Company”). Payment of the Separation Pay described below is contingent on your agreement to and compliance with the terms of this Agreement. Neither this offer to you nor the Company’s entering into this Agreement shall constitute an admission by the Company.
LICENSE AGREEMENT by and between ALTUS PHARMACEUTICALS INC. and CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. DATED FEBRUARY 20, 2009 Portions of this Exhibit are omitted and have been filed separately with the Secretary of the Commission pursuant to...License Agreement • May 11th, 2009 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • Massachusetts
This License Agreement (this “Agreement”), is made as of February 20, 2009 (the “Effective Date”), by and between Altus Pharmaceuticals Inc., a Delaware corporation (“Altus”), and Cystic Fibrosis Foundation Therapeutics, Inc., a Maryland corporation (“CFFT”) and collectively, with Altus, the “Parties,” and each a “Party”).
